IP Library Patent Application 17797680
Patent Application
App. No. 17/797,680

NUCLEIC ACID SEQUENCE DETECTION BY ENDONUCLEASE DIGESTION AND MASS SPECTROMETRY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/797,680
Abstract

A method of nucleic acid analysis is described, the method including the steps of (a) providing a sample comprising a plurality of end-blocked polynucleotides derived from a biological source; (b) digesting at least some of the end-blocked polynucleotides with a nucleic acid-directed endonuclease that targets a sequence of interest to produce polynucleotide fragments that comprise the sequence of interest and a ligatable end generated by endonuclease cleavage; (c) ligating a moiety to the ligatable end to produce a moiety-target polynucleotide construct; and (d) detecting the moiety-target polynucleotide construct or a transcription or translation produce produced from the moiety-target polynucleotide construct using mass spectrometry. The moiety may be an adaptor sequence with a promoter for RNA polymerase. The moiety may be a chemical moiety that is highly amenable to flight and detection in a mass spectrometer.

Claims (36)

1 . A method of genetic analysis, comprising:

(a) providing a complex mixture comprising a plurality of end-blocked polynucleotides;

(b) digesting at least some of the end-blocked polynucleotides with a nucleic acid-directed endonuclease that cleaves a target polynucleotide comprising a sequence of interest to produce, if the sequence of interest is present in the complex mixture, a polynucleotide that comprises:

the sequence of interest and

at least one ligatable end generated by endonuclease cleavage;

(c) ligating a moiety to a ligatable end of the polynucleotide under conditions in which the moiety cannot be ligated to a polynucleotide that lacks a ligatable end to produce a moiety-target polynucleotide construct;

(d) detecting, using mass spectrometry, the moiety-target polynucleotide construct or a transcription or translation product produced from the moiety-target polynucleotide;

(e) correlating the detection of the moiety-target polynucleotide with the presence of the sequence of interest in the complex mixture.

2 . A method of genetic analysis, comprising:

(a) providing a complex mixture comprising a plurality of end-blocked polynucleotides;

(b) digesting at least some of the end-blocked polynucleotides with a nucleic acid-directed endonuclease that cleaves a target polynucleotide comprising a sequence of interest to produce, if the sequence of interest is present in the complex mixture, a polynucleotide that comprises:

the sequence of interest and

at least one ligatable end generated by endonuclease cleavage;

(c) ligating a moiety to a ligatable end of the polynucleotide under conditions in which the moiety cannot be ligated to a polynucleotide that lacks a ligatable end to produce a moiety-target polynucleotide construct, wherein the moiety is a nucleotide adaptor comprising an RNA promoter and the moiety-target polynucleotide construct is configured so that transcription initiated at the promoter transcribes at least a portion of the sequences of interest to produce RNA products;

(d) translating the RNA products to produce a polypeptide or mixture of polypeptides;

(e) detecting, using mass spectrometry, the polypeptide or mixture of polypeptides; and

(f) correlating the detection of the polypeptide or mixture of polypeptides with the presence of the sequence of interest in the complex mixture.

3 . The method of claim 2 wherein the in vitro transcription and translation are coupled.

4 . A method of genetic analysis, comprising:

(a) providing a complex mixture comprising a plurality of end-blocked polynucleotides;

(b) digesting at least some of the end-blocked polynucleotides with a nucleic acid-directed endonuclease that cleaves a target polynucleotide comprising a sequence of interest to produce, if the sequence of interest is present in the complex mixture, a polynucleotide that comprises:

the sequence of interest and

at least one ligatable end generated by endonuclease cleavage;

(c) ligating a moiety to a ligatable end of the polynucleotide under conditions in which the moiety cannot be ligated to a polynucleotide that lacks a ligatable end to produce a moiety-target polynucleotide construct, wherein the moiety is a nucleotide adaptor comprising an RNA promoter and the moiety-target polynucleotide construct is configured so that transcription initiated at the promoter transcribes at least a portion of the sequences of interest to produce RNA products;

(d) detecting, using mass spectrometry, the RNA products; and

(e) correlating the detection of the RNA products with the presence of the sequence of interest in the complex mixture.

5 . A method of genetic analysis, comprising:

(a) providing a complex mixture comprising a plurality of end-blocked polynucleotides;

(b) digesting at least some of the end-blocked polynucleotides with a nucleic acid-directed endonuclease that cleaves a target polynucleotide comprising a sequence of interest to produce, if the sequence of interest is present in the complex mixture, a polynucleotide that comprises:

the sequence of interest and

at least one ligatable end generated by endonuclease cleavage;

(c) ligating a moiety to a ligatable end of the polynucleotide under conditions in which the moiety cannot be ligated to a polynucleotide that lacks a ligatable end to produce a moiety-target polynucleotide construct, wherein the moiety is a an adaptor linked to a mass label to produce adaptored polynucleotides linked to the mass label;

(d) detecting, using mass spectrometry, the RNA adaptored polynucleotides linked to the mass label; and

(e) correlating the detection of the adaptored polynucleotides linked to the mass label with the presence of the sequence of interest in the complex mixture.

6 . The method of claim 1 in which the nucleic acid-directed endonuclease is a CRISPR-associated protein (Cas) and a guide RNA.

7 . The method of claim 1 in which the sequence of interest is a gene sequence of a strain of bacteria.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2022
From: CRAWFORD, EMILY D.
To: CHAN ZUCKERBERG BIOHUB, INC.
Reel/Frame 060732/0933 →